Global Antiobesity Market Research Report 2017 tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analyzing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the Copper Strips market. This research report offers in-depth analysis of the market size (revenue), market share, major market segments, and different geographic regions, forecast for the next five years, key market players, and premium industry trends. It also focuses on the key drivers, restraints, opportunities and challenges. The report will make detailed analysis mainly on above questions and in-depth research on the development environment, market size, development trend, operation situation and future development trend of Antiobesity market on the basis of stating current situation of the industry in 2017 so as to make comprehensive organization and judgment on the competition situation and development trend of Antiobesity market and assist manufacturers and investment organization to better grasp the development course of Antiobesity market.
Leading companies operating in the global Antiobesity market profiled in the report are Arena Pharmaceutical, GlaxoSmithKline, Novo-nordisk, Orexigen Therapeutics, F. Hoffmann-La Roche.
This report segments the global Antiobesity market On the basis of application the global Antiobesity market is segmented into Incretin mimetics/GLP-1 agonists, SNDRIs, Lipase inhibitors, Serotonin receptor agonists, Sympathomimetic-GABA receptor agonists, and Sympathomimetics. For comprehensive understanding of market dynamics, the global Antiobesity market is analyzed across key geographies namely Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa. Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.
Inquire for free sample copy at:
The global antiobesity market was estimated to be around $1.7 billion as of 2016. The global antiobesity made up around 3.2% of the overall gastrointestinal drugs market in 2016. The antiobesity market was the fifth largest market in the global gastrointestinal drugs market in 2016.
Strategic acquisitions of small companies by market leaders in the market to strengthen their market position is one of the major trend in the market. For instance, in August 2015 Novo Nordisk acquired Calibrium LLC and MB2 LLC, a US based biopharmaceutical research companies. Through the acquisitions Novo Nordisk focuses on expanding its obesity and diabetes product line by integrating Calibrium LLC and MB2 LLC companies.
Increase in number of antiobesity drug approvals from the regulatory bodies such as FDA in the US and EMA in EU is an emerging trend in the market. For instance, in September 2014, Contrave antiobesity drug received FDA approval for its commercialization in the US market. Contrave is a combination of two already FDA-approved drugs, naltrexone and bupropion and is used in the treatment of obesity.
15 Chapters are covered in this Report to deeply display the global Antiobesity market.
Chapter 1, to describe Antiobesity Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyse the top manufacturers of Antiobesity, with sales, revenue, and price of Antiobesity, in 2016and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Antiobesity, for each region, from 2012to 2017;
Chapter 5, 6, 7,8and 9, to analyse the key regions, with sales, revenue and market share by key countries in these regions;
Chapter 10and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;
Chapter 12, Antiobesity market forecast, by regions, type and application, with sales and revenue, from 2017to 2022;
Chapter 13, 14 and 15, to describe Antiobesity sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source.
Available complete report of this research with TOC and List of Figures at:
The vast market research data included in the study is the result of extensive primary and secondary research activities. Surveys, personal interviews, and inputs from industry experts form the crux of primary research activities and data collected from trade journals, industry databases, and reputable paid sources form the basis of secondary research. The report also includes a detailed qualitative and quantitative analysis of the market, with the help of information collected from market participants operating across key sectors of the market value chain. A separate analysis of macro- and micro-economic aspects, regulations, and trends influencing the overall development of the market is also included in the report.
This report provides in-depth analysis of the Antiobesity and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period: 2017 – 2022, considering 2016 as the base year. It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market. This study also provides key insights about market drivers, restraints, opportunities, new product launches, approvals, regional outlook, and competitive strategies adopted by the leading players. It profiles leading players in the global Antiobesity market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans Key companies covered as a part of this study include. Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launches, market expansion, and marketing tactics. The global Antiobesity market report caters to various stakeholders in this industry, including investors, device manufacturers, distributors and suppliers for Antiobesity equipment, government organizations, research and consulting firms, new entrants, and financial analysts. Various strategy matrices used in analyzing the Antiobesity market would provide stakeholders vital inputs to make strategic decisions accordingly.
MarketInsightsReports provides syndicated market research reports to industries, organizations or even individuals with an aim of helping them in their decision making process. These reports include in-depth market research studies i.e. market share analysis, industry analysis, information on products, countries, market size, trends, business research details and much more. MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
+1 (704) 266-3234 | firstname.lastname@example.org
Connect With us on: